An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections by Shanks, RMQ et al.
An Eye to a Kill: Using Predatory Bacteria to Control
Gram-Negative Pathogens Associated with Ocular
Infections
Robert M. Q. Shanks1, Viral R. Davra2, Eric G. Romanowski1, Kimberly M. Brothers1, Nicholas A. Stella1,
Dipti Godboley2, Daniel E. Kadouri2*
1Department of Ophthalmology, Campbell Laboratory of Ophthalmic Microbiology, University of Pittsburgh, Pittsburgh, United States of America, 2Department of Oral
Biology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America
Abstract
Ocular infections are a leading cause of vision loss. It has been previously suggested that predatory prokaryotes might be
used as live antibiotics to control infections. In this study, Pseudomonas aeruginosa and Serratia marcescens ocular isolates
were exposed to the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. All tested S. marcescens
isolates were susceptible to predation by B. bacteriovorus strains 109J and HD100. Seven of the 10 P. aeruginosa isolates
were susceptible to predation by B. bacteriovorus 109J with 80% being attacked by M. aeruginosavorus. All of the 19 tested
isolates were found to be sensitive to at least one predator. To further investigate the effect of the predators on eukaryotic
cells, human corneal-limbal epithelial (HCLE) cells were exposed to high concentrations of the predators. Cytotoxicity assays
demonstrated that predatory bacteria do not damage ocular surface cells in vitro whereas the P. aeruginosa used as a
positive control was highly toxic. Furthermore, no increase in the production of the proinflammatory cytokines IL-8 and
TNF-alpha was measured in HCLE cells after exposure to the predators. Finally, injection of high concentration of predatory
bacteria into the hemocoel of Galleria mellonella, an established model system used to study microbial pathogenesis, did
not result in any measurable negative effect to the host. Our results suggest that predatory bacteria could be considered in
the near future as a safe topical bio-control agent to treat ocular infections.
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Introduction
In an era of increasing antibiotic resistance among bacterial
pathogens, the search for new antibiotics and novel treatments for
infections caused by these organisms is a priority among
researchers. One novel treatment is biological therapy using
specific bacteriophage for controlling the infecting pathogen [1–3].
Another novel treatment that might hold the potential to treat
antibiotic resistant infections are predatory bacteria [4]. Recently,
several studies have highlighted the ability of predatory bacteria
Bdellovibrio spp. and Micavibrio spp. to prey on Gram-negative
pathogens. Among the pathogens which were evaluated were
bacteria associated with oral infections [5–7], gastrointestinal
infections [8], zoonotic infection [9], pathogens associated with
food processing and spoilage [10–12], as well as bacteria linked to
systemic infections, burns and wounds [13]. Although the data
published so far supports the claim that predatory bacteria could
be used to control human pathogens, there is still concern
regarding the toxic effects of administering large numbers of
Gram-negative bacteria as live antibiotics. Therefore, treatment of
local infections where the pathogens are easily accessible to topical
or locally injected treatment would be ideal candidates to
demonstrate a ‘‘proof of concept’’ that infections can be
successfully treated with predatory bacteria.
One such local bacterial infection that is treated by direct
administration of antibiotic to the site of infection is keratitis,
infection of the cornea. Bacterial keratitis can be caused by both
Gram-positive and Gram-negative pathogens. Common Gram-
negative pathogens associated with keratitis are Pseudomonas
aeruginosa and Serratia marcescens [14–16]. Bacterial keratitis is
usually localized to an area of the cornea and is treated with
antibiotic solutions delivered topically to the eye.
The first step in demonstrating that predatory bacteria can
successfully treat bacterial keratitis caused by Gram-negative
bacteria is showing that the predatory bacteria can kill Gram-
negative bacteria isolated from keratitis cases. Secondly, we must
show that the predatory bacteria are non-toxic and non-
inflammatory to human cells. In this study we tested whether
predatory bacterial species Bdellovibrio bacteriovorus and Micavibrio
aeruginosavorus were able to kill keratitis isolates of P. aeruginosa and
S. marcescens, including antibiotic-resistant isolates, in vitro. We also
tested whether B. bacteriovorus and M. aeruginosavorus were cytotoxic
and inflammatory to human corneal-limbal epithelial cells (HCLE)
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in vitro. To further test whether these predatory bacteria were
pathogenic, we used the Galleria monella pathogenesis model to
determine whether B. bacteriovorus and M. aeruginosavorus reduced
the viability of the G. monella larvae.
Materials and Methods
Bacterial strains, and growth conditions
The predatory bacteria used in the study were Bdellovibrio
bacteriovorus strains HD100, 109J (ATCC 43826) and Micavibrio
aeruginosavorus strain ARL-13 [17,18]. Ten Pseudomonas aeruginosa
and nine Serratia marcescens isolates were examined in this study. All
clinical isolates were isolated from keratitis patients by Dr.
Ritterband at the New York Eye Infirmary and Regis Kowalski
at the UPMC Eye Center. Many of these bacteria were
fluoroquinolone resistant and previously used in antibiotic efficacy
studies [19,20]. Pseudomonas aeruginosa and Serratia marcescens were
grown with aeration and maintained in LB media. Predator stock-
lysates were prepared by co-culturing the predators in the presence
of host bacteria suspended in diluted nutrient broth (DNB), a 1:10
dilution of nutrient broth amended with 3 mM MgCl2 and 2 mM
CaCl2 [13]. E. coli ZK2686 and P. aeruginosa UCBPP-PA14 were
used as host cells for B. bacteriovorus and M. aeruginosavorus,
respectively. The co-cultures were incubated on a rotary shaker
at 30
˚
C. Fresh predator cultures were prepared as previously
described [13,21,22], in brief, 2 ml of overnight-grown host cells
(,16109 CFU/ml) were added to 2 ml of predatory bacteria
taken from a stock-lysate and suspended in 20 ml DNB. The co-
cultures were incubated for 24 hrs at 30uC to reach ,16108
PFU/ml predator’s cells. At this point, the lysates were filtered
through a 0.45 mm Millex-HV pore-size filter (Millipore, Billerica,
MA) in order to remove any residual host cells (harvested
predator).
Predation Experiments
Predation experiments were conducted as previously described
[13]. Five ml co-cultures were prepared by adding 0.5 ml of
washed host cells to 0.5 ml of freshly harvested predator bacteria
in DNB media. The cultures were incubated at 30uC for 48 hrs.
The capability of B. bacteriovorus and M. aeruginosavorus to prey was
evaluated by the reduction in prey cell viability in the predator co-
cultures. Cell viability was measured by dilution plating and CFU
enumeration at 24 and 48 hrs. Each co-culture was conducted
twice in triplicate.
Cytotoxicity assays
B. bacteriovorus and M. aeruginosavorus were prepared as described
above using 5 ml of washed host cells and 5 ml of freshly harvested
predator in 50 ml DNB media. The co-cultures were incubated for
24 and 36 hrs for B. bacteriovorus and M. aeruginosavorus, respectively.
Thereafter, the lysates were filtered four times through a 0.45-mm
Millex-HV pore-size filter to remove any residual host cells. The
filtered harvested lysate was washed twice by centrifugation,
15,000 rpm for 30 min, and resuspended in 2 ml of DNB. Aliquots
of the predator preparation was removed and plated on agar
plates, to confirm that the samples are free from host cells. Samples
were also taken to determine predator concentration using
standard double-layered agar method [23]. Purifications were
conducted on 3 and 4 separate occasions for M. aeruginosavorus and
B. bacteriovorus, respectively.
Cytotoxicity assays were conducted as described [24] with some
modifications, Human corneal-limbal epithelial (HCLE) [25] cells
were cultured in 24-well plates until they were confluent. HCLE
cells were grown in Keratinocyte serum-free medium (KSFM) with
L-Glutamine, supplemented with 25 mg/ml BPE, 0.2 ng/ml EGF,
and 1 mM CaCl2. HCLE cells were seeded without antibiotics to
prevent interference of antibiotics in subsequent assays. The plates
were incubated in an incubator at 37uC with 5% CO2. The wells
were washed 3 times using PBS, pH 7.4 (Sigma-Aldrich, St. Louis,
MO) and 450 ml of KSFM media was added to each well.
Thereafter, wells were inoculated with 50 ml of each predator prep
(,0.2–1.16109 PFU/well for B. bacteriovorus strains and ,26108
PFU/ well for M. aeruginosavorus) or predator free DNB control for
maximum viability. Other controls included 0.25% of triton X-
100 to measure total killing and 50 ml of DNB washed P. aeruginosa
PA14 (,2.56107 CFU/well) as a positive control for bacterial
cytotoxicity. Cell cultures were incubated for 4 and 24 hrs. After
the incubation, aliquots of medium were removed from each well,
centrifuged to remove bacteria, and stored at –20uC for
subsequent pro-inflammatory cytokine analysis. The cells were
then washed three times with PBS. Alamar Blue viability reagent
(Invitrogen) in KSFM containing amikacin (10 mg/ml) was added
to each well (500 ml/well) to assess cell viability. Fluorescence was
measured after 1.5 hrs of incubation using a Synergy 2 microplate
reader (Biotek) at 500/27 nm excitation and 620/40 nm emission
wavelength. Experiments were conducted four times using B.
bacteriovorus and three times using M. aeruginosavorus. Each
experiment was conducted in quadruplicate (4 cell culture wells).
Cytokine analysis
HCLE supernatants were collected at 4 and 24 hrs post
bacterial exposure. Four biological samples were used for ELISA
and also tested on two different days with a different harvest
sample set. IL-8 and TNFa ELISAs were run on the 4 and 24-
hour sample sets according to manufacturer’s instructions (for IL-
8, R & D SystemsH; for TNFa, Thermo Scientific Pierce
Biotechnology). Upon completion of the assay, samples were read
according to the manufacturer’s instructions on a Synergy 2 plate
reader (BioTek). Samples were graphed and statistical analysis was
performed using GraphPad Prism 5 using one-way ANOVA with
Tukey’s post-hoc test.
Toxicity assay in Galleria mellonella invertebrate infection
model
Viability experiments were conducted as described previously
[26] with some modifications. Galleria mellonella larvae were
obtained from New York worms (New York Worms, Glen Cove,
NY). Larvae were in their final instar stages and had equal size and
weight (330630 mg). B. bacteriovorus strains, 109J, HD100, and M.
aeruginosavorus ARL-13 were grown and concentrated as descried
for the cytotoxicity assays. The predators were suspended in
phosphate buffered saline (PBS), pH 7.4 (Sigma-Aldrich, St. Louis,
MO). Final predator concentration 26109 PFU/ml. Five micro-
liters of each sample was injected into the hemocoel of each larva
via the last left proleg using a Hamilton 25 ml syringe and 30.5-
gauge needle. Prior to use, the syringes were sterilized using
bleach. The syringes were cleaned with 70% alcohol and distilled
water and the needles were changed between every sample. In
addition to the predators, worms were also injected with 5 ml of
PBS buffer (negative control) and 5 ml of 86104 CFU/ml P.
aeruginosa PA14 (positive control). After injection, the worms were
incubated at 30
˚
C and the numbers of live larvae were scored for
11 days. Larvae were considered dead when they display no
movement in response to gentle shaking of the dish or touching
with a pipette tip. Six petri dishes containing 5 worms were
assigned to each experimental and control groups (30 worms total
for each sample).
Predation and Ocular Infection
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Statistical Analysis
Graphpad Prism 5 software was used to perform statistical
analysis. This analysis consisted of One-way ANOVA with
Tukey’s multiple comparison test.
Results
Predation by B. bacteriovorus and M. aeruginosavorus
When exposed to the predators, all of the isolates were found to
be susceptible to at least one predator. All S. marcescens isolates were
found to be susceptible to predation by both B. bacteriovorus 109J
and HD100, with cell reduction ranging from 1.7 log10 to greater
than 5 log10, compared to the initial cell concentration and the
predator free control (Table 1). 100% of the tested P. aeruginosa
isolates were reduced by B. bacteriovorus HD100. However, only
70% of the isolates were reduced by the 109J strain. Eight of the
10 P. aeruginosa isolates were reduced by M. aeruginosavorus with a
greater than 2-log10 reduction measured for 87% of the predation
positive strains (Table 1). It was previously shown that M.
aeruginosavorus ARL-13 is able to use P. aeruginosa as prey; however,
it is unable to utilize S. marcescens [13,22]. Therefore, in this study,
M. aeruginosavorus was not tested on S. marcescens.
Cytotoxicity B. bacteriovorus and M. aeruginosavorus to
HCLE cells
As a first step towards judging the suitability of predatory
bacteria for ocular infections, we tested whether B. bacteriovorus and
M. aeruginosavorus were cytotoxic to HCLE cells in vitro. Bacteria
were co-incubated with HCLE cells at an MOI of ,100 with a
known cytotoxic P. aeruginosa strain [27] as a positive control, and
.800 for each of the predatory bacteria. Bacteria and HCLEs
were co-incubated for 4 and 24 hours, then bacteria were
removed and HCLE cells were tested for viability using the
fluorescent vital stain alamar blue. Whereas P. aeruginosa was highly
cytotoxic at both time points, the predatory bacteria were not
significantly different from the mock at either 4 or 24 hrs (p.0.05,
ANOVA, with Tukey’s post-test) (Figure 1).
Production of pro-inflammatory cytokines following
exposure to predatory bacteria
Because the predatory bacteria used in this study are Gram-
negative bacteria, we predicted that they may cause adverse
inflammatory effects upon exposure to ocular cells. Supernatants
of HCLE cells co-incubated for four hrs with B. bacteriovorus and M.
aeruginosavorus in the above noted cytotoxicity studies and were
analyzed for proinflammatory cytokines IL-8 and TNF-a. These
cytokines were chosen because they are expressed by ocular
surface cells exposed to bacteria [28,29]. Whereas the positive
Table 1. Predation of S. marcescens and P. aeruginosa ocular isolates by predatory bacteria.
Bacteria and strain Time0 (CFU/ml)
Control (Log10
change)
B. bacteriovorus 109J
(Log10 change)
B. bacteriovorus HD100
(Log10 change)
M. aeruginosavorus ARL-13
(Log10 change)
Serratia marcescens
K912 1.256108 +0.7460.46 –1.760.15 –2.6260.03 na
K1064 9.436108 –0.0460.06 –2.6360.06 –4.5560.10 na
K1097 4.326108 +0.0960.13 –3.5660.07 –4.1760.10 na
K1154 5.646108 –0.096 0.05 –3.9160.06 –4.246 0.01 na
K1885 3.486108 +0.2260.02 –3.760.24 –4.660.19 na
K1496 6.066108 +0.0760.10 –3.7460.01 –5.2860.08 na
K2093 3.916108 +0.0760.08 –2.8860.06 –3.9460.2 na
K2119 1.256108 +0.2460.11 –3.560.24 –5.4860.06 na
K2282 1.286108 +0.8960.03 –4.3961.13 –3.0560.29 na
Pseudomonas aeruginosa
PaA 3.566108 +0.2960.18 –4.9760.13 –3.560.19 –1.1060.50*
PaB 5.006108 +0.2360.03 –3.6760.01 –2.7460.22* +0.1260.08Y
PaC 7.036108 +0.0760.06 –2.1360.15 –3.9160.03 –2.9860.08
PaD 3.266108 –0.6960.02 –2.0660.27 –3.6660.16 –2.8660.21*
Pa16 8.286108 –0.0760.03 –3.58 60.06 –2.1860.24* –0.1960.09
K2418 4.916108 +0.2560.10 +0.1860.06 –3.0160.42* –2.7460.40
K2409 1.076109 –0.0860.03 –4.1860.14 –4.4860.06 –2.0360.16*
K2222 8.516108 –0.0160.26 –2.7860.11 –2.1960.43 –2.8560.04*
K2414 7.266108 +0.1660.08 –0.0460.33Y –1.1660.23 –2.8560.10*
K2421 8.386108 +0.2960.10 –0.2960.21 –2.6160.22 –3.5160.43
Co-cultures were prepared by adding host cells to harvested predator cells (,16107 PFU final concentration) or predator free control. Values represent the maximum
Log10 change measured following 24 or 48 (*) hrs of incubation (compared to t0). Each experiments was conducted twice in triplicate yielding similar results. Value
representing the mean and standard error from one representative experiment.
n.a.- not applicable.
Time 0- initial host concentration (CFU/ml).
+ = Increase in host numbers.
– = Decrease in host numbers.
doi:10.1371/journal.pone.0066723.t001
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control, P. aeruginosa, elicited a strong and significant induction of
both cytokines, neither IL-8 nor TNF-a was found to be elevated
above the mock negative control in HCLE supernatants co-
incubated with any of the three predatory bacteria (Figure 2A–B).
The same pattern was observed after co-incubation of the
predatory and positive control bacteria at 24 hrs for IL-8;
however, TNF-a levels were undetectable (data not shown).
In vivo effect of predatory bacteria on G. mellonella
G. mellonella was recently recognized as a suitable host model
system to study microbial pathogenesis and innate immunity [30–
34]. The G. mellonella system generally demonstrates a positive
correlation between virulence factors found in mammals to those
isolated in the insect, emphasizing the ability to utilize the system
to bridge between in vitro studies and vertebrates [26]. In order to
further evaluate the potential risk of using predatory bacteria G.
mellonella worms were exposed to high concentrations of each
predator. All of the worms injected with P. aeruginosa PA14 (46102
CFU/worm) were nonviable 24 hrs post-injection. However,
worms injected with PBS, B. bacteriovorus 109J, HD100 (1.16107
PFU/worm) and M. aeruginosavorus ARL-13 (0.96107 PFU/worm)
were all viable 24 hrs post-injection. 11 days post-injection, the
viability of the worms were 96.6%, 100%, 96.6% and 93.3%
viability for the control, B. bacteriovorus 109J, HD100 and M.
aeruginosavorus ARL-13, respectively. Furthermore, no change in
larva pigmentation was observed in the predator-infected worms
(Data not shown). In G. mellonella the change in color indicates
melanization caused by the host immune response to the microbial
Figure 1. Cytotoxicity to human corneal-limbal epithelial cells in vitro. Alamar blue vital stain was used to measure cytotoxicity from positive
control P. aeruginosa strain PA14 (average MOI = 111), detergent lysis (LYSIS), medium only negative control (MOCK), and experimental strains B.
bacteriovorus strain 109J (average MOI = 4720), B. bacteriovorus strain HD100 (average MOI = 1039), and M. aeruginosavorus (Mica, average MOI =
853). HCLE viability was measured after 4 h (A) and 24 h (B) of exposure. Total independent data points from 4 experiments are shown. Asterisks
indicate significant differences (p,0.001, ANOVA with Tukey’s post-test). Only PA14 was significantly different than MOCK. Error bars indicate one
standard deviation.
doi:10.1371/journal.pone.0066723.g001
Figure 2. Inflammatory response of human corneal-limbal epithelial cells to predatory bacteria in vitro. Pro-inflammatory cytokines IL-8
(panel A) and TNF-a (panel B) were measured using ELISA assays. Cell supernatants taken from HCLE cells after 4 hrs of incubation with positive
control Pseudomonas aeruginosa strain PA14 (average MOI = 111), detergent lysis (LYSIS), medium only negative control (DNB), and experimental
strains B. bacteriovorus strain 109J (avgerage MOI = 4720), B. bacteriovorus strain HD100 (average MOI = 1039), and M. aeruginosavorus (Mica,
average MOI = 853). Total independent data points from 2 experiments are shown. Asterisks indicate significant differences (p,0.001, ANOVA with
Tukey’s post-test). Only PA14 was significantly different than MOCK. Error bars indicate one standard deviation.
doi:10.1371/journal.pone.0066723.g002
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challenge [26]. Thus, based on our finding it could be concluded,
that unlike other pathogens, predatory bacteria do not provoke an
aggressive innate immune response when injected.
Discussion
In this study, we have demonstrated that M. aeruginosavorus ARL-
13 is able to prey on clinical isolates of P. aeruginosa isolated from
ocular infections. This finding is in line with earlier reports
regarding the host specificity of this predator and its ability to
attack P. aeruginosa [13,22,35]. Our data also suggest that both B.
bacteriovorus 109J and HD100 are capable of using S. marcescens as a
host. This finding is in agreement with a study reporting a 3 log10
reduction in cell viability of a non clinical isolate of S. marcescens
following predation by B. bacteriovorus 109J [13]. In addition, B.
bacteriovorus 109J and HD100 were able to prey on P. aeruginosa.
However, the ability of the HD100 strain to attack was broader
than that of 109J, preying on 100% and 70% of the isolates,
respectively. The narrower ability of B. bacteriovorus 109J to prey on
P. aeruginosa is aligned with a recent report in which B. bacteriovorus
109J was able to reduce only 1 out of 4 P. aeruginosa examined
strains [5], as wall as earlier findings showing a limited ability of
some B. bacteriovorus to prey on P. aeruginosa [8,36]. The different
host- and intra-species strain- specificity demonstrated by Bdello-
vibrio spp. and Micavibrio spp. is well documented. Furthermore,
predation ability was found to be specific to the B. bacteriovorus
strain used, with different B. bacteriovorus strains demonstrating
unique host specificity [8,13,22,35–38]. As the mechanisms that
define the predator’s host specificity are not fully known, we could
only speculate on the reason why certain bacteria are recognized
as a host while others are not.
A major concern that needs to be addressed when evaluating
the potential use of predatory bacteria as topical live-antibiotics
are the risks associated with applying Gram-negative microorgan-
isms to human cells. To this end, we have conducted cytotoxicity
assays in which HCLE cells were exposed to high concentrations
of the predators. Our data indicate that predatory bacteria are
significantly less cytotoxic than the control P. aeruginosa. Low
cytotoxicity was observed even after an extended exposure period.
Although only a small number of studies regarding the safety of
using predatory bacteria were conducted, the current data does
support the claims that predatory bacteria could be considered
safe. In a review article published by Dwider at al [4] the authors
cited a study in which Bdellovibrio was injected into mice rabbits
and guinea pigs and were found to be non pathogenic to the
animals [39]. In a separate study conducted by Lenz and Hespell
[40], the investigators attempted to grow the predatory bacteria B.
bacteriovorus 109J, Bacteriovorax stolpii UKi2 and Peredibacter starrii
A3.12 in the presence of eukaryotic cells. It was concluded that
predatory bacteria are unable to grow on hamster kidney cells,
mouse liver cells and bovine mammary gland cells. Furthermore,
the predators did not grow within rabbit ova, following injection,
nor were they able to grow in media containing rabbit ova
extracts. Thus, it seems that mammalian cells could not be used by
the predators as prey and could not support predator proliferation
in the absent of a Gram-negative host. The inability of the
predator to grow and establish itself in the intestinal microflora
was shown in a study in which Bdellovibrio strain MS7 was fed to
Channel catfish, northern leopard frogs, and mice. The predator
viability also declined when inoculated into rabbit ileal loops. As
Bdellovibrio could not proliferate in vivo it reduces the risk of
permanent establishment within the mammalian host, rendering
the predator, in the study, as nonpathogenic [41].
In a recent study conducted at the University of Nottingham
[9], the in vivo effect of Bdellovibrio in a poultry vertebrate model was
examined. It was found that B. bacteriovorus HD100, which was
orally administered to chicks, caused no negative health effects on
the birds. Furthermore, the authors were not able to recover viable
Bdellovibrio from the gut flora, fecal matter or drinking water of the
predator-inoculated birds, concluding that the risk of spreading
predatory bacteria during treatment is low. Bdellovibrio treatment
was also found to improve the well being of the birds colonized
with Salmonella Enteritidis in the therapeutic trail.
An additional concern of applying live predatory bacteria is the
risk of inadvertently causing inflammation which in could inhibit
wound healing and increase the risk of tissue damage. In this study
we have demonstrated that exposure to high doses of the predators
did not elevate the production of the proinflammatory cytokines
IL-8 and TNF-alpha by HCLE cells. Experimental evidence
supports that neutrophils attracted by the bacteria-induced
inflammation are a major cause of scarring and tissue damage
associated with vision loss in keratitis [42]. The low cytotoxic
activity of B. bacteriovorus HD100 LPS and its reduced ability to
induce TNF-alpha and IL-6, compared to an E. coli control, was
previously reported in a study using a human macrophage cell line
[43]. The authors attributed their findings to the unique structure
of the B. bacteriovorus LPS Lipid A molecule. Unlike Lipid A from
many Gram-negative bacteria that contain negatively charged
phosphate groups, the B. bacteriovorus Lipid A molecule has a-D-
mannose residues which reduced its affinity to LPS receptors
thereby lowering inflammation. Our data confirm that B.
bacteriovorus HD100 and 109J do not enhance proinflammatory
cytokines production. Our data also demonstrate, for the first time,
that as reported for B. bacteriovorus o, M. aeruginosavorus also does not
enhance inflammation.
Although, our data show that predatory bacteria have little or
no adverse effect when applied to human cell cultures, we were
interested to evaluate the effect of predatory bacteria in vivo. To
address whether predatory bacteria a tolerated by eukaryotic cells
in vivo, a G. mellonella microbial pathogenesis model was selected.
Although, we did not measure the viability of the predators within
the worm over time, we might still conclude that injecting
relatively high doses of predatory bacteria do not provoke any
measurable toxic or harmful effect to the worm. G. mellonella is
recognized as a suitable host model system to study the
pathogenesis of both bacteria and yeast and was used to examine
pathogenic attributes of many human pathogens including
pathogens associated with eye infections [26,30,32]. These studies
established the use of G. mellonella for a variety of applications such
as: examining microbial pathogenicity and lethality, evaluating
microbial growth and proliferation, isolating virulence factors, and
inspecting putative virulence mechanisms [30,32-34,44]. Since the
innate immune systems of mammals and insects have several
features in common [31], G. mellonella could also be used as a
model system for studying the host innate immune response to
microbial infection as well as identifying microbial virulence
factors that mediate the immune response [33,45].
The potential use of predatory bacteria as a bio-control agent to
treat eye infections was first suggested some 40 years ago. In a
study conducted in 1972 [46] the ‘‘pro-biotic’’ ability of E. coli and
B. bacteriovorus to impact the pathogenesis of Shigella flexneri in
animal modules was examined. It was shown that the B.
bacteriovorus was able to reduce the severity of keratoconjunctivitis
induced by S. flexneri in a rabbit keratoconjunctivitis model. The
simultaneous inoculation of Bdellovibrio with S. flexneri was able to
prevent the development of the infection. The rate of development
of typical keratoconjunctivitis was also decreased when Bdellovibrio
Predation and Ocular Infection
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was administered within 48 hrs of the initial S. flexneri infection. In
a more recent study, the ability of B. bacteriovorus 109J to inhibit
growth of and reduce the adherence of Moraxella bovis to Madin-
Darby bovine kidney (MDBK) cells, used to mimic bovine
keratoconjunctivitis, was confirmed [47]. The ability of Bdellovibrio
to survive and prey in human fluids was also demonstrated in an
experiment in which B. bacteriovorus 109J was abele to significantly
reduce biofilms of Aggregatibacter actinomycetemcomitans in the
presence of human saliva that contains many of the same
antimicrobial compounds as do tears [5].
In conclusion, our work demonstrates that predatory bacteria
have the ability to attack ‘‘real-life’’ Gram-negative human
pathogens associated with ocular infection. Furthermore, in vitro
studies had revealed that the presence of high concentrations of
predatory bacteria don’t appear to be harmful to human cells.
These findings, coupled with the ability of predator bacteria to
prey in conditions that might be encountered in the eye,
emphasize the potential use of applying predator bacteria as a
topical agent to treat eye infections caused by pathogens which are
resistant to traditional antimicrobials. The efficacy of predatory
bacteria to control infection using in vivo models of ocular infection
should be the focus of future studies. The long-term goal is to
develop a topical predator bacteria product, which might include a
single or multispecies predator bacteria mix and could be used
alone or in concert with traditional antimicrobial therapies.
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